SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DZOO who wrote (168)5/6/1997 1:48:00 PM
From: Dauntless   of 834
 
Your comments are all valid. I have medical device experience but very little with pharmaceuticals - I can't imagine any way TXB would NOT have to do more studies in order to use their product with Retavase.

However, lots of people use TPA & streptokinase so there will be a market with these two drugs. In addition, there is the HIT application. If these two markets are successfully entered then a corporate partnership is likely and financing additional clinicals is less of a problem. Is this too simple??
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News